0.008834 0.000000 0.000000 -0.000000 0.008834 0.000000 0.000000 -0.000000 0.008834 0.000000 0.000000 0.000000 Weng, J.H. Wei, T.Y.W. Hsieh, Y.C. Huang, C.C.F. Wu, P.Y.G. Chen, E.S.W. Huang, K.F. Chen, C.J. Tsai, M.D. http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic 24 90.000 90.000 90.000 113.205 113.205 113.205 C3 H7 N O2 89.093 y ALANINE L-peptide linking C6 H15 N4 O2 1 175.209 y ARGININE L-peptide linking C4 H8 N2 O3 132.118 y ASPARAGINE L-peptide linking C4 H7 N O4 133.103 y ASPARTIC ACID L-peptide linking C3 H7 N O2 S 121.158 y CYSTEINE L-peptide linking C5 H10 N2 O3 146.144 y GLUTAMINE L-peptide linking C5 H9 N O4 147.129 y GLUTAMIC ACID L-peptide linking C2 H5 N O2 75.067 y GLYCINE peptide linking C6 H10 N3 O2 1 156.162 y HISTIDINE L-peptide linking C6 H13 N O2 131.173 y ISOLEUCINE L-peptide linking C6 H13 N O2 131.173 y LEUCINE L-peptide linking C6 H15 N2 O2 1 147.195 y LYSINE L-peptide linking C5 H11 N O2 S 149.211 y METHIONINE L-peptide linking C5 H11 N O2 Se 196.106 n SELENOMETHIONINE L-peptide linking C9 H11 N O2 165.189 y PHENYLALANINE L-peptide linking C5 H9 N O2 115.130 y PROLINE L-peptide linking C3 H7 N O3 105.093 y SERINE L-peptide linking C4 H9 N O3 119.119 y THREONINE L-peptide linking C4 H10 N O6 P 199.099 n PHOSPHOTHREONINE PHOSPHONOTHREONINE L-peptide linking C9 H11 N O3 181.189 y TYROSINE L-peptide linking C5 H11 N O2 117.146 y VALINE L-peptide linking US Biochemistry BICHAW 0033 0006-2960 54 6219 6229 10.1021/acs.biochem.5b00500 26389808 Uncovering the Mechanism of Forkhead-Associated Domain-Mediated TIFA Oligomerization That Plays a Central Role in Immune Responses. 2015 110 1 CCD 2014-10-26 ADSC QUANTUM 315 SINGLE WAVELENGTH M x-ray 1 1.0 1.0 BL13B1 NSRRC 1.0 SYNCHROTRON NSRRC BEAMLINE BL13B1 16848.533 TRAF-interacting protein with FHA domain-containing protein A UNP RESIDUES 10-150 1 man polymer 1455.349 TRAF-interacting protein with FHA domain-containing protein A UNP RESIDUES 1-12 1 syn polymer Putative MAPK-activating protein PM14,Putative NF-kappa-B-activating protein 20,TRAF2-binding protein Thr9 phosphorylated N-terminal peptide no yes EETVTCLQ(MSE)TVYHPGQLQCGIFQSISFNREKLPSSEVVKFGRNSNICHYTFQDKQVSRVQFSLQLFKKFNSSVLSF EIKN(MSE)SKKTNLIVDSRELGYLNK(MSE)DLPYRC(MSE)VRFGEYQFL(MSE)EKEDGESLEFFETQFILSPRSLL Q EETVTCLQMTVYHPGQLQCGIFQSISFNREKLPSSEVVKFGRNSNICHYTFQDKQVSRVQFSLQLFKKFNSSVLSFEIKN MSKKTNLIVDSRELGYLNKMDLPYRCMVRFGEYQFLMEKEDGESLEFFETQFILSPRSLLQ A polypeptide(L) no yes MTSFEDAD(TPO)EET MTSFEDADTEET B polypeptide(L) n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n Human sample 1 141 TIFA, T2BP 9606 Homo sapiens 562 Escherichia coli Biological sequence pET43.1 1 3.30 62.76 VAPOR DIFFUSION, SITTING DROP 2.1 M DL-malic acid pH7.0 6.5-7.5 277 repository Initial release Database references 1 0 2015-10-21 1 1 2015-10-28 Taiwan Academia Sinica Taiwan National Health Research Institutes N RCSB Y PDBJ 2015-03-06 REL REL 9606 Human Homo sapiens sample 1 12 GLU 10 n 1 GLU 10 A GLU 11 n 2 GLU 11 A THR 12 n 3 THR 12 A VAL 13 n 4 VAL 13 A THR 14 n 5 THR 14 A CYS 15 n 6 CYS 15 A LEU 16 n 7 LEU 16 A GLN 17 n 8 GLN 17 A MSE 18 n 9 MSE 18 A THR 19 n 10 THR 19 A VAL 20 n 11 VAL 20 A TYR 21 n 12 TYR 21 A HIS 22 n 13 HIS 22 A PRO 23 n 14 PRO 23 A GLY 24 n 15 GLY 24 A GLN 25 n 16 GLN 25 A LEU 26 n 17 LEU 26 A GLN 27 n 18 GLN 27 A CYS 28 n 19 CYS 28 A GLY 29 n 20 GLY 29 A ILE 30 n 21 ILE 30 A PHE 31 n 22 PHE 31 A GLN 32 n 23 GLN 32 A SER 33 n 24 SER 33 A ILE 34 n 25 ILE 34 A SER 35 n 26 SER 35 A PHE 36 n 27 PHE 36 A ASN 37 n 28 ASN 37 A ARG 38 n 29 ARG 38 A GLU 39 n 30 GLU 39 A LYS 40 n 31 LYS 40 A LEU 41 n 32 LEU 41 A PRO 42 n 33 PRO 42 A SER 43 n 34 SER 43 A SER 44 n 35 SER 44 A GLU 45 n 36 GLU 45 A VAL 46 n 37 VAL 46 A VAL 47 n 38 VAL 47 A LYS 48 n 39 LYS 48 A PHE 49 n 40 PHE 49 A GLY 50 n 41 GLY 50 A ARG 51 n 42 ARG 51 A ASN 52 n 43 ASN 52 A SER 53 n 44 SER 53 A ASN 54 n 45 ASN 54 A ILE 55 n 46 ILE 55 A CYS 56 n 47 CYS 56 A HIS 57 n 48 HIS 57 A TYR 58 n 49 TYR 58 A THR 59 n 50 THR 59 A PHE 60 n 51 PHE 60 A GLN 61 n 52 GLN 61 A ASP 62 n 53 ASP 62 A LYS 63 n 54 LYS 63 A GLN 64 n 55 GLN 64 A VAL 65 n 56 VAL 65 A SER 66 n 57 SER 66 A ARG 67 n 58 ARG 67 A VAL 68 n 59 VAL 68 A GLN 69 n 60 GLN 69 A PHE 70 n 61 PHE 70 A SER 71 n 62 SER 71 A LEU 72 n 63 LEU 72 A GLN 73 n 64 GLN 73 A LEU 74 n 65 LEU 74 A PHE 75 n 66 PHE 75 A LYS 76 n 67 LYS 76 A LYS 77 n 68 LYS 77 A PHE 78 n 69 PHE 78 A ASN 79 n 70 ASN 79 A SER 80 n 71 SER 80 A SER 81 n 72 SER 81 A VAL 82 n 73 VAL 82 A LEU 83 n 74 LEU 83 A SER 84 n 75 SER 84 A PHE 85 n 76 PHE 85 A GLU 86 n 77 GLU 86 A ILE 87 n 78 ILE 87 A LYS 88 n 79 LYS 88 A ASN 89 n 80 ASN 89 A MSE 90 n 81 MSE 90 A SER 91 n 82 SER 91 A LYS 92 n 83 LYS 92 A LYS 93 n 84 LYS 93 A THR 94 n 85 THR 94 A ASN 95 n 86 ASN 95 A LEU 96 n 87 LEU 96 A ILE 97 n 88 ILE 97 A VAL 98 n 89 VAL 98 A ASP 99 n 90 ASP 99 A SER 100 n 91 SER 100 A ARG 101 n 92 ARG 101 A GLU 102 n 93 GLU 102 A LEU 103 n 94 LEU 103 A GLY 104 n 95 GLY 104 A TYR 105 n 96 TYR 105 A LEU 106 n 97 LEU 106 A ASN 107 n 98 ASN 107 A LYS 108 n 99 LYS 108 A MSE 109 n 100 MSE 109 A ASP 110 n 101 ASP 110 A LEU 111 n 102 LEU 111 A PRO 112 n 103 PRO 112 A TYR 113 n 104 TYR 113 A ARG 114 n 105 ARG 114 A CYS 115 n 106 CYS 115 A MSE 116 n 107 MSE 116 A VAL 117 n 108 VAL 117 A ARG 118 n 109 ARG 118 A PHE 119 n 110 PHE 119 A GLY 120 n 111 GLY 120 A GLU 121 n 112 GLU 121 A TYR 122 n 113 TYR 122 A GLN 123 n 114 GLN 123 A PHE 124 n 115 PHE 124 A LEU 125 n 116 LEU 125 A MSE 126 n 117 MSE 126 A GLU 127 n 118 GLU 127 A LYS 128 n 119 LYS 128 A GLU 129 n 120 GLU 129 A ASP 130 n 121 ASP 130 A GLY 131 n 122 GLY 131 A GLU 132 n 123 GLU 132 A SER 133 n 124 SER 133 A LEU 134 n 125 LEU 134 A GLU 135 n 126 GLU 135 A PHE 136 n 127 PHE 136 A PHE 137 n 128 PHE 137 A GLU 138 n 129 GLU 138 A THR 139 n 130 THR 139 A GLN 140 n 131 GLN 140 A PHE 141 n 132 PHE 141 A ILE 142 n 133 ILE 142 A LEU 143 n 134 LEU 143 A SER 144 n 135 SER 144 A PRO 145 n 136 PRO 145 A ARG 146 n 137 ARG 146 A SER 147 n 138 SER 147 A LEU 148 n 139 LEU 148 A LEU 149 n 140 LEU 149 A GLN 150 n 141 GLN 150 A MET 1 n 1 MET 1 B THR 2 n 2 THR 2 B SER 3 n 3 SER 3 B PHE 4 n 4 PHE 4 B GLU 5 n 5 GLU 5 B ASP 6 n 6 ASP 6 B ALA 7 n 7 ALA 7 B ASP 8 n 8 ASP 8 B TPO 9 n 9 TPO 9 B GLU 10 n 10 GLU 10 B GLU 11 n 11 GLU 11 B THR 12 n 12 THR 12 B author_and_software_defined_assembly PISA 2 dimeric 950 -3 8490 A MSE 18 modified residue A MSE 9 MET A MSE 90 modified residue A MSE 81 MET A MSE 109 modified residue A MSE 100 MET A MSE 116 modified residue A MSE 107 MET A MSE 126 modified residue A MSE 117 MET B TPO 9 modified residue B TPO 9 THR 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 1_555 x,y,z identity operation 0.0000000000 0.0000000000 0.0000000000 A N LEU 41 A N LEU 32 A O PHE 137 A O PHE 128 A O ILE 142 A O ILE 133 A N VAL 20 A N VAL 11 A N THR 19 A N THR 10 A O LEU 125 A O LEU 116 A O PHE 124 A O PHE 115 A N VAL 117 A N VAL 108 A O ARG 118 A O ARG 109 A N ILE 97 A N ILE 88 A N LEU 96 A N LEU 87 A O LEU 103 A O LEU 94 A O TYR 58 A O TYR 49 A N GLY 50 A N GLY 41 A N PHE 49 A N PHE 40 A O GLN 69 A O GLN 60 A N PHE 75 A N PHE 66 A O SER 84 A O SER 75 A N ILE 87 A N ILE 78 A O MSE 109 A O MSE 100 1 A CG LYS 63 A CG LYS 54 1 Y 1 A CD LYS 63 A CD LYS 54 1 Y 1 A CE LYS 63 A CE LYS 54 1 Y 1 A NZ LYS 63 A NZ LYS 54 1 Y 1 A CG LYS 93 A CG LYS 84 1 Y 1 A CD LYS 93 A CD LYS 84 1 Y 1 A CE LYS 93 A CE LYS 84 1 Y 1 A NZ LYS 93 A NZ LYS 84 1 Y 1 A CG GLU 129 A CG GLU 120 1 Y 1 A CD GLU 129 A CD GLU 120 1 Y 1 A OE1 GLU 129 A OE1 GLU 120 1 Y 1 A OE2 GLU 129 A OE2 GLU 120 1 Y 1 A CG GLU 132 A CG GLU 123 1 Y 1 A CD GLU 132 A CD GLU 123 1 Y 1 A OE1 GLU 132 A OE1 GLU 123 1 Y 1 A OE2 GLU 132 A OE2 GLU 123 1 Y 1 A CG GLN 150 A CG GLN 141 1 Y 1 A CD GLN 150 A CD GLN 141 1 Y 1 A OE1 GLN 150 A OE1 GLN 141 1 Y 1 A NE2 GLN 150 A NE2 GLN 141 1 Y 1 B OG1 THR 12 B OG1 THR 12 1 Y 1 B CG2 THR 12 B CG2 THR 12 1 Y 1 A A SG NH2 CYS ARG 15 38 1.19 1 A B OG OE1 SER GLU 53 5 1.21 1 A B NH1 O1P ARG TPO 67 9 1.95 1 A GLN 27 -95.76 -75.29 1 A MSE 90 -147.82 26.12 1 A LYS 93 -58.66 -72.86 1 A SER 100 80.78 0.90 186.460 44.6320 16.050 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.9260 0.8880 HYDROGENS HAVE BEEN ADDED IN THE RIDING POSITIONS 0.2386 0.2134 0.2145 3.1200 20.0000 226 4543 4.7000 99.3700 0.0040 0.0000 RANDOM 1 THROUGHOUT 0.000 0.3540 0.3960 0.8000 0.8000 1.2000 MAXIMUM LIKELIHOOD MASK 3.1200 20.0000 0 1240 0 0 1240 153 0.3210 0.3160 3.2020 17 324 341 20 100.0000 3.100 20.000 4YM4 4922 0.161 0.035 0.164 0.947 1 23.556 6.300 107113 21.800 100.000 0.885 3.100 3.210 471 0.904 0.206 0.909 0.955 1 19.200 0 100.000 0.671 3.210 3.340 478 0.939 0.145 0.687 0.954 1 22.100 0 100.000 0.450 3.340 3.490 474 0.995 0.095 0.461 0.923 1 23.100 0 100.000 0.325 3.490 3.670 478 0.984 0.069 0.332 0.948 1 23.100 0 100.000 0.214 3.670 3.900 480 0.994 0.045 0.219 0.985 1 23.100 0 100.000 0.152 3.900 4.200 479 0.995 0.032 0.155 0.955 1 22.800 0 100.000 0.097 4.200 4.620 488 0.997 0.021 0.099 0.952 1 22.500 0 100.000 0.079 4.620 5.270 500 0.998 0.017 0.081 0.917 1 22.200 0 100.000 0.099 5.270 6.610 513 0.998 0.022 0.102 1.111 1 21.300 0 100.000 0.040 6.610 20.000 561 0.999 0.009 0.041 0.769 1 18.800 0 100.000 data scaling HKL-2000 refinement REFMAC 5.7.0032 data extraction PDB_EXTRACT 3.15 data reduction HKL-2000 phasing PHENIX Truncated Human TIFA, MET-THR-SER-PHE-GLU-ASP-ALA-ASP-TPO-GLU-GLU-THR Truncated Human TIFA in complex with its Thr9 phosphorylated N-terminal peptide 1-15 1 N N 2 N N A GLY 29 A GLY 20 HELX_P A ILE 34 A ILE 25 5 AA1 6 covale 1.308 both A GLN 17 A C GLN 8 1_555 A MSE 18 A N MSE 9 1_555 covale 1.312 both A MSE 18 A C MSE 9 1_555 A THR 19 A N THR 10 1_555 covale 1.311 both A ASN 89 A C ASN 80 1_555 A MSE 90 A N MSE 81 1_555 covale 1.310 both A MSE 90 A C MSE 81 1_555 A SER 91 A N SER 82 1_555 covale 1.323 both A LYS 108 A C LYS 99 1_555 A MSE 109 A N MSE 100 1_555 covale 1.315 both A MSE 109 A C MSE 100 1_555 A ASP 110 A N ASP 101 1_555 covale 1.322 both A CYS 115 A C CYS 106 1_555 A MSE 116 A N MSE 107 1_555 covale 1.311 both A MSE 116 A C MSE 107 1_555 A VAL 117 A N VAL 108 1_555 covale 1.328 both A LEU 125 A C LEU 116 1_555 A MSE 126 A N MSE 117 1_555 covale 1.311 both A MSE 126 A C MSE 117 1_555 A GLU 127 A N GLU 118 1_555 covale 1.318 both B ASP 8 B C ASP 8 1_555 B TPO 9 B N TPO 9 1_555 covale 1.310 both B TPO 9 B C TPO 9 1_555 B GLU 10 B N GLU 10 1_555 SIGNALING PROTEIN Complex, FHA domian, adaptor, SIGNALING PROTEIN TIFA_HUMAN UNP 1 10 Q96CG3 EETVTCLQMTVYHPGQLQCGIFQSISFNREKLPSSEVVKFGRNSNICHYTFQDKQVSRVQFSLQLFKKFNSSVLSFEIKN MSKKTNLIVDSRELGYLNKMDLPYRCMVRFGEYQFLMEKEDGESLEFFETQFILSPRSLLQ TIFA_HUMAN UNP 2 1 Q96CG3 MTSFEDADTEET 10 150 4YM4 10 150 Q96CG3 A 1 1 141 1 12 4YM4 1 12 Q96CG3 B 2 1 12 7 5 anti-parallel parallel anti-parallel anti-parallel anti-parallel anti-parallel parallel anti-parallel anti-parallel anti-parallel A GLU 39 A GLU 30 A PRO 42 A PRO 33 A PHE 136 A PHE 127 A LEU 143 A LEU 134 A THR 14 A THR 5 A TYR 21 A TYR 12 A TYR 122 A TYR 113 A GLU 129 A GLU 120 A ARG 114 A ARG 105 A PHE 119 A PHE 110 A LEU 96 A LEU 87 A VAL 98 A VAL 89 A ARG 101 A ARG 92 A LEU 103 A LEU 94 A TYR 58 A TYR 49 A THR 59 A THR 50 A VAL 47 A VAL 38 A GLY 50 A GLY 41 A VAL 68 A VAL 59 A LYS 76 A LYS 67 A LEU 83 A LEU 74 A ASN 89 A ASN 80 A LYS 108 A LYS 99 A ASP 110 A ASP 101 208 P 42 3 2